Objective:To evaluate the clinical efficacy of 125I seed implantation combined with chemotherapy in the treatment of non-small cell lung carcinoma(NSCLC) and its complications.Methods:Combined treatment group(n=42) received CT-guided interstitial 125I seed implantation(PD=8-10 Gy/h),and three days later they were given TAX+DDP intravenous chemotherapy.Control group(n=46) only received TAX+DDP chemotherapy.The dosage was selected based on the same reference standard as the treatment group.The therapeutic eff...